Quadrature Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.7M Buy
+161,500
New +$2.7M 0.05% 251
2025
Q1
Sell
-77,930
Closed -$1.72M 1466
2024
Q4
$1.72M Sell
77,930
-90,093
-54% -$1.99M 0.03% 328
2024
Q3
$3.03M Sell
168,023
-249,837
-60% -$4.5M 0.07% 201
2024
Q2
$6.79M Buy
417,860
+325,858
+354% +$5.29M 0.11% 156
2024
Q1
$1.3M Buy
92,002
+72,555
+373% +$1.02M 0.02% 409
2023
Q4
$203K Buy
+19,447
New +$203K ﹤0.01% 981
2022
Q3
Sell
-27,308
Closed -$205K 1087
2022
Q2
$205K Sell
27,308
-55,444
-67% -$416K 0.01% 623
2022
Q1
$776K Buy
+82,752
New +$776K 0.03% 306
2021
Q3
Sell
-99,112
Closed -$982K 1029
2021
Q2
$982K Sell
99,112
-38,655
-28% -$383K 0.04% 316
2021
Q1
$1.59M Buy
137,767
+120,667
+706% +$1.39M 0.08% 221
2020
Q4
$165K Buy
+17,100
New +$165K 0.01% 742
2020
Q3
Sell
-165,931
Closed -$2.04M 909
2020
Q2
$2.04M Buy
165,931
+56,724
+52% +$699K 0.23% 133
2020
Q1
$980K Sell
109,207
-381,610
-78% -$3.42M 0.23% 125
2019
Q4
$4.81M Sell
490,817
-461,550
-48% -$4.52M 0.18% 133
2019
Q3
$6.56M Buy
952,367
+491,798
+107% +$3.39M 0.32% 94
2019
Q2
$4.24M Buy
460,569
+434,945
+1,697% +$4.01M 0.28% 95
2019
Q1
$402K Buy
+25,624
New +$402K 0.03% 368
2018
Q1
Sell
-30,102
Closed -$571K 752
2017
Q4
$571K Sell
30,102
-113,010
-79% -$2.14M 0.05% 309
2017
Q3
$2.52M Buy
+143,112
New +$2.52M 0.32% 82
2017
Q2
Sell
-48,852
Closed -$1.57M 768
2017
Q1
$1.57M Buy
48,852
+39,652
+431% +$1.27M 0.11% 203
2016
Q4
$334K Sell
9,200
-349,517
-97% -$12.7M 0.02% 508
2016
Q3
$16.5M Buy
358,717
+263,869
+278% +$12.1M 1.44% 10
2016
Q2
$4.76M Buy
94,848
+49,467
+109% +$2.48M 0.35% 73
2016
Q1
$2.43M Buy
+45,381
New +$2.43M 0.34% 82
2015
Q4
Sell
-29,610
Closed -$1.67M 523
2015
Q3
$1.67M Buy
+29,610
New +$1.67M 0.56% 54
2015
Q2
Sell
-11,125
Closed -$693K 204
2015
Q1
$693K Buy
+11,125
New +$693K 1.01% 35